Richard DiMarchi - Assembly Biosciences Insider

Assembly Biosciences Inc -- USA Stock  

USD 45.54  0.26  0.57%


Dr. Richard DiMarchi is Independent Director of Assembly Biosciences, Inc. Dr. DiMarchi is a cofounder of Assembly Pharmaceuticals and has served on its board since inception in 2012. Dr. DiMarchi currently holds the Cox Distinguished Professor of Biochemistry and Gill Chair in Biomolecular Sciences at Indiana University. Dr. DiMarchi was a cofounder and board member of biotechnology companies Ambrx and Marcadia, current founder of Assembly and Calibrium Biotech, and advisor to venture firms 5AM, Twilight Ventures, and others. Dr. DiMarchi retired as Group Vice President at Eli Lilly Company, where he provided leadership for more than two decades in biotechnology, endocrine research, and product development
Age: 61  Director Since 2014  Ph.D    
646 706-5208
DiMarchi previously served as a board member of the biotechnology trade group BIO, Isis and Millennium BioTherapeutics. His current research is focused on developing macromolecules with enhanced therapeutic properties through biochemical and chemical optimization, an approach he has termed chemicalbiotechnology.Dr. DiMarchi received his PhD in Biochemistry from Indiana University, and completed his postdoctoral studies at the Rockefeller University.

Richard DiMarchi Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (29.25) % which means that it has lost $29.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (74.86) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

Assembly Biosciences, Inc., a biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus infection and to restore health to a dysbiotic microbiome in the United States. Assembly Biosciences Inc (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 65 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Assembly Biosciences Inc to your portfolio

Top Management

Assembly Biosciences Inc Leadership Team
Adam Zlotnick, Founder
Uri Lopatin, President, Ph.D
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
William Ringo, Chairman, MBA
Susan Mahony, Director
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance

Assembly Biosciences Performance Indicators